Crowdonomics
WatchlistPortfolio
Biomedican inc

Reg CF · Preferred Stock · Aug 2021

ClosedReached targetReg CFPreferred Equity
via WeFunderView campaign
Raised
$220.5K / $1.1M max
21% of ceiling · target hit day 2
Investors
167
$1.4K avg
Post-money valuation
$56.6M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$329K$165K$0
188940
Aug 15, 2021 · openedSep 30, 2021 · last reading
Target ($200K) hit — Aug 17, 2021, day 2Deadline Apr 30, 2022 — 212 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2019–FY2020 · hover for source
$0
−$971K
FY2019
$0
−$971K
FY2020
RevenueNet income
Metric
FY2019 reviewed*
FY2020 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$971,290
-$971,290
Taxes paid
$0
$0
Balance sheet
Cash
$134,712
$134,712
Accounts receivable
$0
$0
Total assets
$222,406
$222,406
Short-term debt
$167,073
$167,073
Long-term debt
$318,396
$318,396
Total liabilities
$485,469
$485,469
Other
Headcount
—
9

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$56.4M ($50.1M early bird)
Post-money$56.6M
Price / share$4.50
Shares offered50,000

Perks

First $200K investors will invest at $4 per share and a $50.1M pre-money valuationfirst $200K

Offering details

Target$200,000
Max$1,069,999
Min investment$250
OpenedAug 15, 2021
DeadlineApr 30, 2022
ClosedOct 1, 2021
Days active47

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-21-000916

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.